• Exchange for Related Positions

      • To
      • Members, Member Firms, and Market Users
      • From
      • Market Regulation Department
      • #
      • CME Group RA1813-5
      • Notice Date
      • 15 November 2018
      • Effective Date
      • 03 December 2018

    • Effective on trade date Monday, December 3, 2018, and pending all relevant CFTC regulatory review periods, this Market Regulation Advisory Notice will supersede CME Group Market Regulation Advisory Notice RA1809-5 from August 13, 2018.  It is being issued to amend Q&A 4 to remove the six CBOT Consecutive Calendar Spread Options from the list of products that are not able to be submitted to CME Clearing through CME ClearPort or CME Direct and were therefore ineligible to be executed as EFRPs.

      Click HERE for full advisory

CME Group is the world’s leading derivatives marketplace. The company is comprised of four Designated Contract Markets (DCMs). 
Further information on each exchange's rules and product listings can be found by clicking on the links to CME, CBOT, NYMEX and COMEX.

© 2026 CME Group Inc. All rights reserved.